Overview

A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711

Status:
Completed
Trial end date:
2020-07-22
Target enrollment:
Participant gender:
Summary
This is a phase I study to assess the effect of itraconazole and rifampicin on the pharmacokinetic parameters of BPI-7711 in Chinese healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Beta Pharma, Inc.
Treatments:
Hydroxyitraconazole
Itraconazole
Rifampin